Loading stock data…
$0.50+0.03 (+6.86%)
Impact BioMedical Inc.
Impact BioMedical Inc. in the Healthcare sector is trading at $0.50 with a market capitalization of $54M. The stock is currently 39% below its 52-week high of $0.83, remaining 8.5% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7,000 | $7,000↓ | $18,000↑ | $7,000 | $0 |
| Gross Profit | — | -$415,000↓ | $17,000↑ | -$4,000 | — |
| Operating Income | -$2.29M↓ | -$1.16M↓ | -$948,000↑ | -$1.15M↓ | -$1.01M |
| Net Income | -$2.29M↓ | $5.25M↑ | -$1.47M↑ | -$14.35M↓ | -$1.27M |
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products ...